STOCK TITAN
  1. Home
  2. Sec-filings
  3. ADCT
  4. [EFFECT] ADC Therapeutics SA SEC Filing

[EFFECT] ADC Therapeutics SA SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 16, 2026 4:00 P.M.
Form: S-3
CIK: 0001771910
Company Name: ADC Therapeutics SA
File Number: 333-294191

Source: View Original Filing on SEC EDGAR

Adc Therapeutics Sa

NYSE:ADCT

View ADCT Stock Overview →

ADCT Rankings

#3411 Ranked by Market Cap
N/A Ranked by Dividends
#84 52-Week Gainer
#362 YTD Gainer
#854 Monthly Gainer
#1046 Ranked by Short %Change

ADCT Latest News

Mar 10, 2026
ADC Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Operational Update
Mar 3, 2026
ADC Therapeutics to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 10, 2026
Mar 2, 2026
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
Feb 24, 2026
ADC Therapeutics to Participate in March Investor Conferences
Feb 23, 2026
ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement

ADCT Latest SEC Filings

Mar 16, 2026
[424B3] ADC Therapeutics SA Prospectus Filed Pursuant to Rule 424(b)(3)
Mar 10, 2026
[S-3] ADC Therapeutics SA Shelf Registration Statement
Mar 10, 2026
[ARS] ADC Therapeutics SA SEC Filing
Mar 10, 2026
[10-K] ADC Therapeutics SA Files Annual Report
Mar 10, 2026
[8-K] ADC Therapeutics SA Reports Material Event

ADCT Stock Data

522.76M
101.64M
Biotechnology
Pharmaceutical Preparations
Link
Switzerland
EPALINGES